ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

AMRX Amneal Pharmaceuticals Holding Co

5.87
0.00 (0.00%)
06 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Amneal Pharmaceuticals Holding Co AMRX NYSE 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.00 0.00% 5.87 09:00:00
개장가 저가 고가 종가 전일 종가
5.87
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
03/05/202419:14EDGAR2Form 8-K - Current report
03/05/202419:00BWAmneal Reports First Quarter 2024 Financial Results
24/04/202421:00BWAmneal Announces U.S. FDA Approval of Over-the-Counter..
16/04/202421:00BWAmneal Launches PEMRYDI RTU®, the First Ready-to-Use Version..
10/04/202421:00BWAmneal to Report First Quarter 2024 Results on May 3, 2024
29/03/202405:05BWAmneal to Ring the Nasdaq Closing Bell on April 2, 2024
26/03/202405:05BWAmneal Receives U.S. FDA Approval for Ciprofloxacin and..
22/03/202421:01EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
22/03/202421:01EDGAR2Form DEF 14A - Other definitive proxy statements
07/03/202407:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/03/202407:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/03/202406:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/03/202406:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/03/202420:13EDGAR2Form 8-K - Current report
01/03/202420:00BWAmneal Reports Fourth Quarter and Full Year 2023 Financial..
01/03/202406:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/02/202422:00BWAmneal Enters into Exclusive European Licensing Agreement..
13/02/202422:00BWAmneal to Participate at Upcoming Investor Conference
09/02/202406:05GLOBEAmneal Announces Complete Response Resubmission for IPX203..
01/02/202406:05BWAmneal to Report Fourth Quarter and Full Year 2023 Results..
10/01/202422:00BWAmneal Launches Complex Generic Fluorometholone Ophthalmic..
05/01/202406:05BWAmneal Launched Record Number of 39 New Retail and..
27/12/202306:10EDGAR2Form 25 - Notification of the removal from listing and..
27/12/202306:05EDGAR2Form 8-A12B - Registration of securities [Section 12(b)]
21/12/202322:00BWAmneal to Participate at the 42nd Annual J.P. Morgan..
16/12/202306:15EDGAR2Form 8-K - Current report
16/12/202306:06EDGAR2Form 8-K/A - Current report: [Amend]
16/12/202306:05BWAmneal Announces Move to Nasdaq
07/12/202322:00BWAmneal and BIAL Announce U.S. Licensing Agreement for..
02/12/202306:15EDGAR2Form SC 13D/A - General statement of acquisition of..
02/12/202306:15EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
01/12/202322:00BWAmneal Expands Portfolio with Addition of Icosapent Ethyl..
20/11/202320:07EDGAR2Form 15-12G - Securities registration termination [Section..
09/11/202308:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/11/202308:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/11/202308:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/11/202308:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/11/202308:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/11/202307:15EDGAR2Form S-8 POS - Securities to be offered to employees in..
09/11/202307:13EDGAR2Form POS AM - Post-Effective amendments for registration..
09/11/202307:12EDGAR2Form POS AM - Post-Effective amendments for registration..
09/11/202307:07EDGAR2Form SC 13D/A - General statement of acquisition of..
09/11/202307:05EDGAR2Form SC 13D/A - General statement of acquisition of..
09/11/202307:03EDGAR2Form SC 13D/A - General statement of acquisition of..
09/11/202306:59EDGAR2Form SC 13D/A - General statement of acquisition of..
09/11/202306:55EDGAR2Form SC 13D/A - General statement of acquisition of..
08/11/202321:40EDGAR2Form 8-K12B - Notification that a class of securities of..
07/11/202320:21EDGAR2Form 8-K - Current report
07/11/202320:00BWAmneal Reports Third Quarter 2023 Financial Results
03/11/202321:00BWAmneal to Participate at Upcoming Investor Conferences

최근 히스토리

Delayed Upgrade Clock